High expression of lncRNA SNHG1 in breast cancer specifically inhibits miR-448, thereby increasing the expression of IDO, promoting Treg differentiation, enhancing immunosuppression, and promoting tumor proliferation and metastasis,96 also providing an advantage for the occurrence of TIE. This evidence concerns the gene IDO1 and breast carcinoma.